- Home
- GDEV vs JUNS Comparison
GDEV vs JUNS Comparison
Compare GDEV & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEV
- JUNS
- Stock Information
- Founded
- GDEV 2009
- JUNS 2015
- Country
- GDEV Cyprus
- JUNS United States
- Employees
- GDEV N/A
- JUNS N/A
- Industry
- GDEV EDP Services
- JUNS
- Sector
- GDEV Technology
- JUNS
- Exchange
- GDEV Nasdaq
- JUNS NYSE
- Market Cap
- GDEV 282.9M
- JUNS 281.4M
- IPO Year
- GDEV N/A
- JUNS 2024
- Fundamental
- Price
- GDEV $20.90
- JUNS $0.84
- Analyst Decision
- GDEV Buy
- JUNS
- Analyst Count
- GDEV 2
- JUNS 0
- Target Price
- GDEV $70.00
- JUNS N/A
- AVG Volume (30 Days)
- GDEV 20.7K
- JUNS 602.5K
- Earning Date
- GDEV 03-18-2025
- JUNS 03-04-2025
- Dividend Yield
- GDEV N/A
- JUNS N/A
- EPS Growth
- GDEV N/A
- JUNS N/A
- EPS
- GDEV 2.04
- JUNS N/A
- Revenue
- GDEV $432,534,000.00
- JUNS N/A
- Revenue This Year
- GDEV N/A
- JUNS N/A
- Revenue Next Year
- GDEV $9.01
- JUNS N/A
- P/E Ratio
- GDEV $10.24
- JUNS N/A
- Revenue Growth
- GDEV N/A
- JUNS N/A
- 52 Week Low
- GDEV $14.26
- JUNS $0.78
- 52 Week High
- GDEV $42.76
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- GDEV 67.29
- JUNS N/A
- Support Level
- GDEV $14.26
- JUNS N/A
- Resistance Level
- GDEV $15.80
- JUNS N/A
- Average True Range (ATR)
- GDEV 1.17
- JUNS 0.00
- MACD
- GDEV 0.50
- JUNS 0.00
- Stochastic Oscillator
- GDEV 63.03
- JUNS 0.00
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.